PharmaMar is a Spanish biopharmaceutical company founded in 1986 that researches, develops, and commercializes oncology treatments derived from marine sources.[1] The company’s corporate identity centers on a wordmark accompanied by an abstract symbol, registered in the United States under the Pharma Mar name.
Design and History
The company’s primary wordmark trademark, filed on August 3, 1999, and registered on August 27, 2002, describes a design element paired with the terms “PHARMA MAR.”[2] The registration specifies that the drawing is lined for the colors light and dark blue. The design element in its entirety and the lower portion of the terms “PHARMA MAR” are light blue, while the top portion of the term “PHARMA” is dark blue.[2] This particular registration was cancelled on May 16, 2009.[3]
A separate trademark filed on January 4, 2008, and registered on September 29, 2009, protects the abstract symbol alone. The mark consists of the color light blue appearing in the whole mark, which consists of a series of two design elements: three lines with hooks and three quadrilaterals.[4] This registration remains active.[5]
In December 2021, PharmaMar launched a new corporate website with a revamped design, describing it as representing “what this company is today, a unique company with more than 30 years of successful history.”[6] The announcement does not document a change to the logo itself.
Meaning and Symbolism
The trademark record describes only its formal elements: three lines with hooks and three quadrilaterals in light blue.[4] Any interpretation of the mark as representing waves, marine life, or other imagery is not supported by the company’s official filings.
Typography and Design
The trademark record for the wordmark confirms a two-tone blue treatment: light blue for the design element and the lower portion of the words, with dark blue reserved for the top portion of “PHARMA.”[2]
Logo Index is an independent educational archive covering logos, visual identities and graphic design history. All trademarks and brand assets remain the property of their respective owners.
